Molina, J., Ait-Khaled, M., Rinaldi, R., Penco, G., Baril, J., Cauda, R., . . . Grp, T. S. (2009). Fosamprenavir/ritonavir in advanced HIV disease (TRIAD): A randomized study of high-dose, dual-boosted or standard dose fosamprenavir/ritonavir in HIV-1-infected patients with antiretroviral resistance.
Citação norma ChicagoMolina, JM, et al. Fosamprenavir/ritonavir in Advanced HIV Disease (TRIAD): A Randomized Study of High-dose, Dual-boosted or Standard Dose Fosamprenavir/ritonavir in HIV-1-infected Patients With Antiretroviral Resistance. 2009.
Citação norma MLAMolina, JM, et al. Fosamprenavir/ritonavir in Advanced HIV Disease (TRIAD): A Randomized Study of High-dose, Dual-boosted or Standard Dose Fosamprenavir/ritonavir in HIV-1-infected Patients With Antiretroviral Resistance. 2009.